A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma study group, Current Diagnostic Pathology, vol.2, issue.1, pp.1361-92, 1994. ,
DOI : 10.1016/S0968-6053(00)80051-4
Hodgkin's lymphomas: classification, diagnosis, and grading, Semin Hematol, vol.36, pp.220-252, 1999. ,
Clinical presentation and treatment of lymphocyte predominance Hodgkin's disease ,
Clinical Presentation, Course, and Prognostic Factors in Lymphocyte-Predominant Hodgkin's Disease and Lymphocyte-Rich Classical Hodgkin's Disease: Report From the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease, Journal of Clinical Oncology, vol.17, issue.3, pp.776-90, 1999. ,
DOI : 10.1200/JCO.1999.17.3.776
Nodular Lymphocyte Predominance Hodgkin's Disease: Long-Term Observation Reveals a Continuous Pattern of Recurrence, Leukemia & Lymphoma, vol.7, issue.15, pp.359-68, 1997. ,
DOI : 10.1007/BF01611185
European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease, Cancer, vol.96, issue.6, pp.1731-1739, 2002. ,
DOI : 10.1002/cncr.10404
Radiotherapy Alone for Lymphocyte-Predominant Hodgkin??s Disease, The Cancer Journal, vol.8, issue.5, pp.377-83, 2002. ,
DOI : 10.1097/00130404-200209000-00008
Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial, Blood, vol.101, issue.11, pp.4285-4294, 2003. ,
DOI : 10.1182/blood-2002-08-2644
Lymphocyte-Predominant Hodgkin???s Lymphoma in Children: Therapeutic Abstention After Initial Lymph Node Resection???A Study of the French Society of Pediatric Oncology, Journal of Clinical Oncology, vol.21, issue.15, pp.2948-52, 2003. ,
DOI : 10.1200/JCO.2003.01.079
Response Assessment of Aggressive Non-Hodgkin???s Lymphoma by Integrated International Workshop Criteria and Fluorine-18???Fluorodeoxyglucose Positron Emission Tomography, Journal of Clinical Oncology, vol.23, issue.21, pp.4652-61, 2005. ,
DOI : 10.1200/JCO.2005.01.891
Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma, Journal of Clinical Oncology, vol.25, issue.5, pp.571-579, 2007. ,
DOI : 10.1200/JCO.2006.08.2305
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas, Journal of Clinical Oncology, vol.17, issue.4, p.1244, 1999. ,
DOI : 10.1200/JCO.1999.17.4.1244
Whole body positron emission tomography using 18F-fluoro- deoxyglucose compared to standard procedures for staging patients with Hodgkin's disease, Haematologica, vol.86, pp.266-73, 2001. ,
Positron emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma, Haematologica, vol.91, pp.482-491, 2006. ,
Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of lowgrade non-Hodgkin's lymphoma (NHL), Annals of Oncology, vol.12, issue.6, pp.825-855, 2001. ,
DOI : 10.1023/A:1011169332265
Utility of FDG-PET scanning in lymphoma by WHO classification, Blood, vol.101, issue.10, pp.3875-76, 2003. ,
DOI : 10.1182/blood-2002-09-2778
Different histopathological subtypes of Hodgkin lymphoma show significantly different levels of FDG uptake, Hematological Oncology, vol.34, issue.3, pp.146-50, 2006. ,
DOI : 10.1002/hon.782
Fluorodeoxyglucose Uptake in Positron Emission Tomography Distinguishes Between Indolent and Aggressive Non-Hodgkin???s Lymphoma, Journal of Clinical Oncology, vol.23, issue.21, pp.4643-51, 2005. ,
DOI : 10.1200/JCO.2005.12.072
Positron Emission Tomography for the Staging of Hodgkin's Lymphoma - Increasing the Body of Evidence in Favor of the Method, Acta Oncologica, vol.41, issue.5, pp.430-436, 2002. ,
DOI : 10.1080/028418602320405014